Interest in strontium and its relation to calcium metabolism dates back over 20 years. At that time, radioactive calcium (Car) was relatively unavailable. It was thought that radioactive strontium (Srr), which was more readily available and which can be detected more simply, might serve as a substitute tracer for Car. Early experiments (1) (2) (3) confirmed this notion in a general way, and several investigators (4) (5) (6) (7) have subsequently proceeded on the assumption that Sr behaves like Ca in the body. Although the urinary excretions of Sr and Ca were found to differ, it has been assumed or demonstrated that as far as the skeleton is concerned, differences in the biological behavior of Ca and Sr are small and perhaps negligible (4, (8) (9) (10) (11) (12) (13) (14) (15) .
Intrinsic interest in Sr was heightened when it was found to be an important product of fallout resulting from the explosion of nuclear devices in the atmosphere. Protection against Sr fallout depends on adequate knowledge of the metabolism of this nuclide, and in the last decade, a large number of studies have been published that deal with various aspects of Sr metabolism (16) .
Clinical interest in Sr developed when Shorr and Carter (17) proposed treating patients with postmenopausal osteoporosis by giving them Sr supplements in the diet (18) . Sr rickets has been known since the early work of Lehnerdt (19, 20) and has been studied subsequently (21) .
To use Sr as a tracer for Ca requires detailed knowledge of the metabolism of these elements. Knowledge of Ca metabolism has progressed considerably in recent years, so that a formal analysis of the metabolic behavior of this element is now possible. This is not true for Sr for several reasons. Sr occurs in the body in only very small quantities, and its concentration in various tissues is known with only moderate precision (22) . Analytical techniques for precisely analyzing small quantities of Sr have been developed only recently (5, 7, 23) . In contrast with Ca studies, Sr concentration in kinetic studies with Srr has generally not been expressed in terms of specific activity (units of radioactivity per unit of mass), the only valid independent parameter. Rather, investigators have used various devices for expressing their results. These have generally fallen into four categories: 1) units of radioactivity per tissue (e.g., percentage of dose in liver); 2) units of radioactivity per unit of Ca (e.g., percentage of dose per milligram of Ca); 3) units of radioactivity per liter of plasma or per liter of plasma cleared per unit time (e.g., percentage of dose per liter of plasma); and 4) the observed ratio, i.e., (Srr/Car) tissue/ (Srr/Car) source, a measure of the relative extraction or concentration of Sr with respect to Ca (24) .
The theoretical and practical difficulties inherent in any one of these modes of expressing results are apparent and will be discussed. We allude to them here to (25) .
METHODS
Experimental. The experimental approach and mode of analysis of Ca metabolism have been described in detail (26) (27) (28) . In brief, a patient was admitted to the metabolic ward on an analytically verified intake of Ca. Ca output in urine and feces was measured throughout the period of study. After a period of adjustment, which was never less than 5 to 6 days, a kinetic study was initiated. Ca45 and Sr8" were injected intravenously at the same time, and their output in urine and feces was measured for several days thereafter. Some time after completion of this first phase, treatment was begun in some patients, and the kinetic study was repeated several weeks later. (27, 29 These experimental facts can correspond to two different systems (Figure 2 ). In the one system, there is a central pool with size remaining constant and specific activity decreasing with time. The other has no central pool of constant size, and the circulating mass decreases with time, the specific activity of the circulating mass remaining constant.
To establish one or the other hypothesis experimentally would require a formal study of Sr metabolism, i.e., measuring its concentration in accessible body compartments and fluids, its rate of ingestion in the food, and its rate of elimination in urine and feces. The analytical difficulties of measuring Sr chemically are well known, so that the task entailed in such a program is hardly justified if there is no intrinsic interest in Sr metabolism.
It is possible, however, to analyze experimental results of Sr metabolism and to compare them with those of Ca metabolism regardless of which scheme of analysis, with or without pool of constant size, is chosen for Sr. This is done by characterizing each of the three routes of loss by a rate constant k, which is defined independently of the scheme of analysis chosen.
In the system with a central pool of constant size (26), the rates of loss from the pool, vu for the urine, vf for the endogenous fecal loss, and vt+ for the skeleton, are considered constant during the experimental period.
Let P = the mass of the pool, and M., Mf, M0+ = the corresponding amounts lost from the pool to urine, feces, Theoretical analysis. When high specific activity Srr is injected intravenously in human subjects, the time-course of the radioactivity in the blood between 0 and 7 days, expressed as counts per minute per milliliter of serum, can be described as a series of four exponential terms, the first three of which become negligible after 1 to 2 days (30) . In other words, the monoexponential portion of the experimentally determined Sr disappearance curve is represented by RB = Ae-as, [1] where RB is concentration of Srr in blood (expressed as percentage of dose per liter of plasma), and A and a are positive numbers. After an iv injection, a portion of the injected radioactivity is excreted in the urine and another portion in the stools. Let R. = radioactivity in urine and RF = radioactivity in feces. If the collection is extended long enough, e.g., > 9 days, the amount of radioactivity circulating at that time becomes negligible and the amount of radioactivity excreted thereafter is small ( Figure 1 ).
If it is assumed that essentially all Srr not recovered in either urine or feces is in the skeleton, one can write
In system with pool a) specific activity varies with time b) pool size remains constant where the various k's have the usual definition of a rate constant (1/time). Inasmuch as P is constant, the various rates v are necessarily constant as well.
When a radioactive tracer is introduced in such a system, the time-course of the disappearance curve can be expressed by a relationship like Equation 1, RSB = Ri e-(Vr/P)t, [4] where RIE = the specific activity of the element in the serum, Ri = the amount of injected radioactivity, and P = the pool size. VT = the sum of the component losses from the pool, VT = Vu + Vf +o+ [5] By combining Equations 4, 5, and 3, a to c, one obtains the relationship RIB = i e-(lu+kf+ko+)t, [6] P which expresses Equation 4 in terms of the rate constants. Equation 6 can also be written as R8B P e [7] where K = ku +kPa+k+. [8] In the system without a central pool of constant size, the amounts, in mass, excreted in urine and feces and deposited in time dt are proportional to the circulating mass M which varies in size with time. One therefore writes:
where dM is the total amount lost from the system in time dt. By combining Equations 9, a to c, and 10, one obtains dM (k. +kf +k.+)M.
[3b] Integration of Equation 11 yields M = MOe-(ku+kf+ko+) t [11] [12] where MO = the mass at t = 0, and M is the mass circulating at time t.
If MO at t = 0 is labeled with a tracer Ri (the amount of radioactivity injected), the specific activity (RaB) at t = 0, expressed as percentage of injected dose per unit mass, is given by Ri RB =MO. [13] In a system without central pool of constant size, this specific activity remains constant throughout the experiment. By combining Equations 12 and 13, one obtains the amount of radioactivity, R, circulating at time t: R = Ri MOe-(ku+kf+ko+)t = Rie-(ku+kf+ko+)t [14] If RB is the amount of circulating radioactivity per unit of plasma volume, the time-course of this parameter can be expressed in terms of Equation 14 as follows: [15] where L = total apparent volume of distribution of the circulating mass ( [18] 1098 E10] 2 If the experimental error is 5%, the absolute error for the mean urine excretion of Ca45 (Table III) is 0.80 (0.05 X 16) and for fecal excretion of Ca450.70 (0.05 X 14). The error for the total excretion is therefore 1.5, which necessarily is the same absolute error for the percentage of dose in bone [100 -(14 + 16)]. Hence the relative error for the percentage of dose in bone is 4 2% (1.5 X 100)/70. The same reasoning applies for Sr, except that the total percentage of the dose excreted in urine and feces is 48; hence, the relative error for bone is larger.
in Table III is about double that of the component values making up the ratio.
The values set out in Table II are not only subject to the analytical errors detailed above, but also to the error involved in deriving K. In all cases, the numerical value of K was derived by the method of least squares applied to the excretion values obtained in the period of 2 to 6 days following injection of the isotopes; the uncertainty attaching to each is about ± 5%.
By adding this error to the error inherent in the percentage of dose excreted and in bone, one can estimate the over-all experimental error of a given rate constant to be be added to the error due to the experimental analysis.
Because Sr metabolism may be formally described in a manner identical with that used for Ca metabolism, the errors inherent in the analysis of Sr metabolism are the same as for Ca metabolism. Hence, combining the experimental with the method error, one arrives at the following error range for the constants:
k. Errors due to the method of analyzing the data. To compare the corresponding rate constants between patients, the error due to the method of calculation must be taken into account as well. The method used was of the same type described elsewhere as the "simplified method" (26, 28) .
In this method, the behavior of the system is described by a single exponential term, and losses from the system prior to homogenization are not taken into account. As compared to the general method, based on the complete, multitermed equation, the simplified method overestimates P and VT and therefore v0+ and vo. The degree of overestimation varies in direct proportion to the magnitude of P and VT, but cannot be predicted unless both the simplified and general methods have been applied to the same study. Since this was not done here, we shall generalize a particular case.
In a patient whose true Ca pool was 6.5 g, but whose Ca pool by the simplified method was 9.2 g (28), we can calculate that by using the simplified instead of the generalized method, K To compare the rate constant of a given patient with that of another subject, the error due to the use of the simplified method (which always underestimates the true value) must therefore With the ratios of the rate constants, however, the error due to the use of the simplified instead of the general method cancels, being identical and in the same direction for both elements, if the experiment is done in the same patient. Hence, the ratios of the rate constants are in error only by approximately the sum of the over-all experimental errors of each rate constant, i.e., Ksr/Kca = + 10%, ku8r/kuca = 4 20%, kf!r/ kfca = ± 20%, and ko+gr/ko+ca = i 16%.
A comparison of the various rate constants listed in Table II indicates that the mean values of the different constants vary from one process to the other, both for Ca and Sr. Also, these mean values fall within a relatively large range (Table II) . With the exception of the rate constants for urine, the ranges of the other constants are similar for Ca and Sr, and their mean values are relatively close to one another.
The question that arises first is whether or not, in a group of subjects as widely different in terms of Ca metabolism as that studied here, the various rate constants for Ca fall outside the range of the combined error, i.e., over-all experimental error approximately half of the ratios of the rate constants fall outside of the experimental error. One may therefore conclude that the failure to find a regression function in any pair is not due solely to the dispersion owing to the experimental error and that none of the metabolic processes of Ca and Sr discussed here can be considered equivalent, i.e., the ratios of the rate constants do not only vary within the limits of error of their mean.
It is nevertheless surprising that as far as fecal excretion and bone uptake are concerned, the two elements seem directly equivalent. This is due to the fact that for an unknown reason the range of variation of the corresponding rate constants for either element is similar. Also, the rate constant for a given patient appears as if placed within this range by chance. Hence, the corresponding ratios of an individual patient's rate constants may differ considerably from the group mean that approximates unity. and urinary rate constants (k,,) of Sr differed significantly from the corresponding Ca constants, the fecal (kf) and bone (k0±) rate constants of the two elements did not so differ.
Values for individual patients of these latter two rate constants appear as if distributed by chance within the experimental range, with the result that the mean ratios of the rate constants of the two elements, kfr/kfa and ko+5r/ko±+a, approach unity. 5. These findings are interpreted to mean that, qualitatively, both Sr and Ca follow the same metabolic pathways, and quantitatively, the use of Sr as a tracer for Ca in a given individual leads only to an approximation of the true value, the degree of error varying unpredictably for a particular case. Whereas all of the parameters of Ca metabolism can be evaluated in terms of unit mass and unit mass per unit time by the combined use of the Ca balance and Car, the use of Sr in studies of Ca metabolism can yield information only in terms of an apparent circulating volume (expressed, for example, in liters of serum) and of rate constants (K, ku, kf, k0+). Sr may be used as a tracer for Ca to measure the mean bone formation rate in groups of individuals whose Ca metabolism is disparate.
